Mark Feinberg, MD

Read Bio

Mark W. Feinberg, MD is a cardiologist and vascular biologist at Brigham and Women’s Hospital (BWH) and a Professor of Medicine at Harvard Medical School, Boston. Dr. Feinberg is Director, Program in Cardiovascular RNA Biology Research at BWH and investigates signaling events that control vascular inflammation and angiogenesis as it relates to a range of ischemic cardiovascular disease states including atherosclerosis and its complications involving ischemic injury in the heart (myocardial infarction) and limb (peripheral artery disease) with a special focus in diabetes. His group has discovered non-coding RNAs (microRNAs and lncRNAs) and their interactors with the aim of translating these findings into novel therapeutic approaches for ischemic cardiovascular and cardiometabolic disease. Dr. Feinberg has held various leadership roles in cardiovascular research including his service on international and national peer review grant study sections, editorial service, and as a Co-Chair of the Brigham Research Institute’s CVDM (Cardiovascular, Diabetes, and Metabolic Disorders) Center. He served as Director of an AHA SFRN Center on cardiometabolic disease and is Associate Program Director of the BWH Cardiology Fellowship training program. He has mentored >50 trainees – many of whom have independent academic careers and have been recognized as recipients of national young investigator awards from the AHA, ACC, or ADA. Dr. Feinberg is an elected member of the American Society of Clinical Investigation (ASCI), Association of University Cardiologists (AUC), and American Association for the Advancement of Science (AAAS).